Literature DB >> 4500983

In vitro-in vivo correlation of drug metabolism--deamination of 1- -D-arabinofuranosylcytosine.

R L Dedrick, D D Forrester, D H Ho.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4500983     DOI: 10.1016/0006-2952(72)90245-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  23 in total

Review 1.  A review of the applications of physiologically based pharmacokinetic modeling.

Authors:  K J Himmelstein; R J Lutz
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

Review 2.  Physiologically based pharmacokinetic models for anticancer drugs.

Authors:  H S Chen; J F Gross
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 3.  Current models in pharmacokinetics: applications in veterinary pharmacology.

Authors:  L D Kinabo; Q A McKellar
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

4.  Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models.

Authors:  H S Chen; J F Gross
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

5.  Clearance concepts in pharmacokinetics.

Authors:  M Rowland; L Z Benet; G G Graham
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

6.  Animal scale-up.

Authors:  R L Dedrick
Journal:  J Pharmacokinet Biopharm       Date:  1973-10

7.  Physiological pharmacokinetics.

Authors:  K B Bischoff
Journal:  Bull Math Biol       Date:  1986       Impact factor: 1.758

8.  Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model.

Authors:  Y Igari; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

9.  Incorporation of ABCB1-mediated transport into a physiologically-based pharmacokinetic model of docetaxel in mice.

Authors:  Susan F Hudachek; Daniel L Gustafson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-25       Impact factor: 2.745

10.  Physiologically based pharmacokinetic model of lapatinib developed in mice and scaled to humans.

Authors:  Susan F Hudachek; Daniel L Gustafson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-01-12       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.